The EU joined with global partners Monday to pledge EUR 7.5 billion in funding for the development of fast and equitable access to safe, effective and affordable diagnostics and vaccines against coronavirus.
The EU joined with global partners Monday to pledge EUR 7.5 billion in funding for the development of fast and equitable access to safe, effective and affordable diagnostics and vaccines against coronavirus.
With the world desperate to develop a vaccine for COVID-19, global leaders, including of France, Germany, Japan and Canada - but not the United States - joined forces in this effort to develop life-saving tools, with a crucial pledge that they be universally available and affordable.
"Only a shared spirit of global solidarity and responsibility will defeat the COVID-19 crisis," said the EU Council's president Charles Michel: "This common spirit is our best defence against a virus that has devastated lives and communities in every corner of the globe."
M Michel said vaccines, treatments and therapies will be crucial for Europe. "But even more critical for our most vulnerable partners with fragile health systems, such as Africa," he added. "They must be at the heart of our solidarity."
Researchers and innovators around the world are working very hard to find solutions to save lives and protect our health. Starting on the 4th of May, the Commission will register pledges from countries and business foundations. On that day, the Commission will also announce the next milestones of a global campaign, which is to kick off an ongoing rolling replenishment.
The Commission is also inviting governments, business leaders, public figures philanthropists, artists and citizens to raise awareness about this global pledging effort. The funds collected will be channelled into three strands: diagnostics, treatments and vaccines.
The countdown to the start of marathon began on the first day of the 2020 World Immunisation Week organised by the United Nations.
The theme this year is #VaccinesWork for All and the campaign will focus on how vaccines, as well as the people who develop, deliver and receive them, work to protect the health of everyone, everywhere.
The worldwide pledging effort – the Coronavirus Global Response - runs until the end of May.
Further information about the effort and how to get involved on the Coronavirus Global Response website